Authorized Generics: FTC Study May Get Jumpstart; PhRMA Paper Finds No Harm
Executive Summary
The Federal Trade Commission's study on the impact of authorized generics could be enhanced under an amendment to the legislation reauthorizing the FDA's Rx user fee program
You may also be interested in...
FDA To Require More Detailed Reporting On Authorized Generics Starting In 2010
Changes in the final rule focus on potential changes in the reporting method.
Authorized Generics Debate Heats Up On Hill, But May Need FTC Study To Boil
Authorized generics have prompted the reintroduction of several bills and questions about FDA's regulatory actions - but any legislative movement likely depends on a pending Federal Trade Commission report
Authorized Generics Debate Heats Up On Hill, But May Need FTC Study To Boil
Authorized generics have prompted the reintroduction of several bills and questions about FDA's regulatory actions - but any legislative movement likely depends on a pending Federal Trade Commission report